Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | PPM1B | O75688 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL1295943 | 1.00 | TP53 (0.39) | TP53CYP3A4ALDH1A1CHRM2CHRM4 | |
| Ethylene Glycol SCHEMBL9893783 | 1.00 | TP53 (0.39) | TP53CYP3A4ALDH1A1CHRM2CHRM4 | |
| Ethylene Glycol SCHEMBL1296485 | 0.95 | PPARG (0.41) | TP53CYP3A4CHRM2CHRM4CHRM5 | |
| SCHEMBL16121021 | 0.95 | ALDH1A1 (0.42) | TP53CYP3A4ALDH1A1CHRM2CHRM4 | |
| SCHEMBL1296512 | 0.95 | ALDH1A1 (0.42) | TP53CYP3A4ALDH1A1CHRM2CHRM4 | |
| SCHEMBL16121103 | 0.95 | ALDH1A1 (0.42) | TP53CYP3A4ALDH1A1CHRM2CHRM4 | |
| SCHEMBL5489415 | 0.95 | ALDH1A1 (0.42) | TP53CYP3A4ALDH1A1CHRM2CHRM4 | |
| Ethylene Glycol SCHEMBL1296186 | 0.94 | PPARG (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Ethylene Glycol SCHEMBL16652589 | 0.94 | PPARG (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Ethylene Glycol SCHEMBL1297012 | 0.94 | PPARG (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9771466-B2 | Glycol ether-based cyclohexanoate ester plasticizers and blends therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-09-26 | — | — | US | claimed |
| US-20150112008-A1 | Glycol Ether-Based Cyclohexanoate Ester Plasticizers and Blends Therefrom | EXXONMOBIL CHEMICAL PATENTS INC. | 2015-04-23 | — | — | US | claimed |
| US-9771466-B2 | Glycol ether-based cyclohexanoate ester plasticizers and blends therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-09-26 | — | — | US | disclosed |
| US-9228147-B2 | Glycol ether-based cyclohexanoate esters, their synthesis and methods of use | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-01-05 | — | — | US | disclosed |
| US-20150112008-A1 | Glycol Ether-Based Cyclohexanoate Ester Plasticizers and Blends Therefrom | EXXONMOBIL CHEMICAL PATENTS INC. | 2015-04-23 | — | — | US | disclosed |
| WO-2012082826-A1 | GLYCOL ETHER-BASED CYCLOHEXANOATE ESTERS, THEIR SYNTHESIS AND METHODS OF USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2012-06-21 | — | — | WO | disclosed |
| US-20120149620-A1 | GLYCOL ETHER-BASED CYCLOHEXANOATE ESTERS, THEIR SYNTHESIS AND METHODS OF USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149620-A1 | GLYCOL ETHER-BASED CYCLOHEXANOATE ESTERS, THEIR SYNTHESIS AND METHODS OF USE | GNE, UGT8, GK | TP53 1842/4885CYP3A4 653/4885ALDH1A1 2138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.